Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia).
Pérez-Alvarez
L
L
Area de Patogenia Viral, CNBF, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Cuevas
M T
MT
Villahermosa
M L
ML
Pedreira
J D
JD
Manjón
N
N
Herrero
I
I
López-Calvo
S
S
Delgado
E
E
de Parga
E V
EV
Medrano
L
L
Thomson
M M
MM
Taboada
J A
JA
Nájera
R
R
D004352:Drug Resistance, Microbial / Q000235:genetics; D018432:Drug Resistance, Multiple / Q000235:genetics; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology*; D016333:HIV Protease / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D008297:Male; D015995:Prevalence; D011995:Recombination, Genetic; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology; D013030:Spain / Q000453:epidemiology
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase; D016333:HIV Protease